Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mafa
|
ENSMUSG00000047591.4 | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_75731886_75732037 | Mafa | 16267 | 0.109479 | 0.86 | 3.0e-17 | Click! |
chr15_75731644_75731838 | Mafa | 16487 | 0.109146 | 0.84 | 1.5e-15 | Click! |
chr15_75747526_75747677 | Mafa | 627 | 0.614288 | 0.55 | 1.5e-05 | Click! |
chr15_75747756_75749006 | Mafa | 153 | 0.930195 | 0.01 | 9.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_118444281_118444538 | 18.14 |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
5567 |
0.18 |
chr9_37359459_37360109 | 13.45 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr12_3364588_3366025 | 11.36 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr13_83721104_83721451 | 10.97 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
104 |
0.95 |
chr7_64505029_64505249 | 9.96 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
3001 |
0.23 |
chr14_24003801_24004259 | 9.48 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
53 |
0.68 |
chr3_108433472_108434154 | 9.39 |
Gm22942 |
predicted gene, 22942 |
7517 |
0.09 |
chr14_55054475_55054712 | 9.23 |
Gm20687 |
predicted gene 20687 |
352 |
0.58 |
chr13_71507941_71508418 | 9.03 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr10_67912089_67912792 | 9.02 |
Zfp365 |
zinc finger protein 365 |
5 |
0.98 |
chr14_64588229_64588406 | 8.82 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
217 |
0.91 |
chr8_65617940_65618821 | 8.80 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr12_29871996_29872873 | 8.58 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr7_54835902_54836140 | 8.56 |
Luzp2 |
leucine zipper protein 2 |
406 |
0.87 |
chr16_50717902_50718053 | 8.51 |
Mir6363 |
microRNA 6363 |
9155 |
0.19 |
chr3_17619540_17619872 | 8.32 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr4_62613321_62613879 | 8.23 |
Rgs3 |
regulator of G-protein signaling 3 |
5920 |
0.18 |
chr5_37162967_37163149 | 8.18 |
Gm1043 |
predicted gene 1043 |
209 |
0.94 |
chr8_23964364_23964545 | 7.85 |
Zmat4 |
zinc finger, matrin type 4 |
35401 |
0.22 |
chr9_86879639_86880662 | 7.82 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr14_66910808_66911486 | 7.74 |
Pnma2 |
paraneoplastic antigen MA2 |
23 |
0.97 |
chr2_10737503_10737690 | 7.73 |
Gm18547 |
predicted gene, 18547 |
156113 |
0.01 |
chr9_29750373_29750537 | 7.61 |
Gm15521 |
predicted gene 15521 |
157945 |
0.04 |
chr1_38835547_38836894 | 7.52 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr11_71763746_71763924 | 7.43 |
Wscd1 |
WSC domain containing 1 |
4841 |
0.2 |
chr3_35341183_35341526 | 7.39 |
Gm25442 |
predicted gene, 25442 |
15740 |
0.23 |
chr6_42324738_42325213 | 7.38 |
Fam131b |
family with sequence similarity 131, member B |
332 |
0.77 |
chr3_53563786_53563999 | 7.37 |
Frem2 |
Fras1 related extracellular matrix protein 2 |
19624 |
0.15 |
chr18_57262231_57262735 | 7.22 |
Gm50200 |
predicted gene, 50200 |
52657 |
0.11 |
chr16_28752897_28753619 | 7.12 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr9_41375999_41376652 | 7.09 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr6_65381206_65381562 | 7.04 |
Qrfprl |
pyroglutamylated RFamide peptide receptor like |
90 |
0.97 |
chr10_41071494_41071665 | 7.03 |
Gpr6 |
G protein-coupled receptor 6 |
706 |
0.62 |
chr2_49620647_49620914 | 6.86 |
Kif5c |
kinesin family member 5C |
1482 |
0.5 |
chr15_99677211_99677393 | 6.83 |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
4635 |
0.1 |
chr1_63445451_63445797 | 6.76 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
267 |
0.93 |
chr13_34133367_34133536 | 6.75 |
Gm36500 |
predicted gene, 36500 |
409 |
0.73 |
chr3_85300020_85300198 | 6.74 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17410 |
0.24 |
chr14_64574262_64574427 | 6.70 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
12987 |
0.15 |
chr10_3863520_3864007 | 6.69 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr15_66286727_66287219 | 6.65 |
Gm27242 |
predicted gene 27242 |
56 |
0.82 |
chr3_103401351_103401502 | 6.61 |
Gm25009 |
predicted gene, 25009 |
8493 |
0.17 |
chr12_79911112_79911786 | 6.60 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
13284 |
0.2 |
chr7_62376881_62377054 | 6.56 |
Magel2 |
melanoma antigen, family L, 2 |
43 |
0.97 |
chr7_46453941_46454093 | 6.55 |
Gm22969 |
predicted gene, 22969 |
3604 |
0.2 |
chr5_116322637_116322998 | 6.48 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
10457 |
0.12 |
chr13_83984413_83984945 | 6.47 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr4_24966254_24966983 | 6.33 |
C230012O17Rik |
RIKEN cDNA C230012O17 gene |
2 |
0.49 |
chr6_5102881_5103033 | 6.32 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
7702 |
0.24 |
chr1_52630448_52631246 | 6.31 |
Nemp2 |
nuclear envelope integral membrane protein 2 |
50 |
0.97 |
chr1_14755119_14756069 | 6.28 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr7_144284592_144285016 | 6.25 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
259 |
0.95 |
chr6_126740592_126740784 | 6.24 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
14 |
0.98 |
chr11_54304287_54304643 | 6.20 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
263 |
0.89 |
chr7_4120189_4120499 | 6.17 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
100 |
0.52 |
chr16_94473045_94473706 | 6.16 |
Ttc3 |
tetratricopeptide repeat domain 3 |
6853 |
0.16 |
chr10_26077807_26077993 | 6.15 |
Tmem200a |
transmembrane protein 200A |
258 |
0.6 |
chrX_81070276_81071390 | 6.14 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr3_88225734_88226126 | 6.08 |
Gm3764 |
predicted gene 3764 |
3 |
0.94 |
chr2_21368204_21368428 | 6.01 |
Gpr158 |
G protein-coupled receptor 158 |
749 |
0.45 |
chr13_28859970_28860121 | 5.97 |
Gm11362 |
predicted gene 11362 |
23170 |
0.15 |
chr1_34583668_34584368 | 5.96 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
4307 |
0.1 |
chr4_46991096_46991621 | 5.81 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
515 |
0.76 |
chr4_128678883_128679084 | 5.79 |
Phc2 |
polyhomeotic 2 |
9755 |
0.18 |
chr1_158362078_158362488 | 5.75 |
Astn1 |
astrotactin 1 |
10 |
0.98 |
chr18_81154041_81154201 | 5.73 |
Gm50423 |
predicted gene, 50423 |
71057 |
0.09 |
chr5_108549866_108550582 | 5.72 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chr7_73208852_73209302 | 5.70 |
Gm20083 |
predicted gene, 20083 |
23274 |
0.14 |
chr1_171380284_171380616 | 5.68 |
Arhgap30 |
Rho GTPase activating protein 30 |
8504 |
0.07 |
chr9_37025991_37026207 | 5.65 |
n-R5s82 |
nuclear encoded rRNA 5S 82 |
300 |
0.89 |
chr7_122478370_122478596 | 5.54 |
Gm14389 |
predicted gene 14389 |
5937 |
0.17 |
chr1_173367824_173368059 | 5.52 |
Cadm3 |
cell adhesion molecule 3 |
246 |
0.91 |
chr4_142267638_142267834 | 5.51 |
Kazn |
kazrin, periplakin interacting protein |
28335 |
0.2 |
chr9_98032555_98033050 | 5.48 |
Clstn2 |
calsyntenin 2 |
181 |
0.96 |
chr14_15785133_15785550 | 5.48 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr12_12904167_12904754 | 5.46 |
4930519A11Rik |
RIKEN cDNA 4930519A11 gene |
90 |
0.95 |
chr11_66846476_66846778 | 5.45 |
Pirt |
phosphoinositide-interacting regulator of transient receptor potential channels |
65354 |
0.11 |
chr8_9770576_9770782 | 5.44 |
Gm47312 |
predicted gene, 47312 |
201 |
0.66 |
chr14_59838019_59838182 | 5.42 |
Gm19716 |
predicted gene, 19716 |
195552 |
0.02 |
chr4_138689318_138689498 | 5.40 |
Pla2g2c |
phospholipase A2, group IIC |
35384 |
0.12 |
chr2_45032079_45032340 | 5.38 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
8539 |
0.22 |
chr4_25799122_25799458 | 5.37 |
Fut9 |
fucosyltransferase 9 |
565 |
0.76 |
chr15_78181729_78182061 | 5.33 |
Gm49694 |
predicted gene, 49694 |
7434 |
0.14 |
chr2_118445342_118445493 | 5.30 |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
6575 |
0.17 |
chr15_25676508_25676697 | 5.30 |
Myo10 |
myosin X |
2092 |
0.31 |
chr15_75566838_75567525 | 5.29 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
35 |
0.96 |
chr2_130397163_130397956 | 5.28 |
Cpxm1 |
carboxypeptidase X 1 (M14 family) |
15 |
0.94 |
chr7_25006742_25006920 | 5.28 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
873 |
0.43 |
chr7_92234788_92235188 | 5.28 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
8 |
0.99 |
chr6_47239363_47240145 | 5.25 |
Cntnap2 |
contactin associated protein-like 2 |
4633 |
0.33 |
chr13_3712791_3713218 | 5.24 |
Gm47695 |
predicted gene, 47695 |
46821 |
0.1 |
chr1_74854703_74855024 | 5.21 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
71 |
0.95 |
chr8_70316978_70317206 | 5.16 |
Cers1 |
ceramide synthase 1 |
1258 |
0.27 |
chr11_42000451_42000692 | 5.15 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
39 |
0.99 |
chr13_71507395_71507881 | 5.11 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20031 |
0.26 |
chr19_38054215_38055320 | 5.10 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr4_66403446_66404232 | 5.07 |
Astn2 |
astrotactin 2 |
644 |
0.81 |
chr14_25636313_25636680 | 5.07 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
20334 |
0.16 |
chr2_94273064_94274137 | 5.06 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr16_46009777_46011157 | 5.05 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr1_3671269_3672324 | 5.05 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chrX_100767602_100767791 | 5.04 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
26 |
0.97 |
chr14_75527756_75528110 | 5.02 |
Cby2 |
chibby family member 2 |
64016 |
0.1 |
chr7_49699721_49700100 | 5.01 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59205 |
0.11 |
chr5_117000840_117001021 | 4.96 |
Gm7478 |
predicted gene 7478 |
57882 |
0.11 |
chr6_122760974_122761350 | 4.96 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
18242 |
0.11 |
chr5_133453797_133453985 | 4.93 |
Gm42625 |
predicted gene 42625 |
10549 |
0.22 |
chr1_79450325_79450959 | 4.91 |
Scg2 |
secretogranin II |
10522 |
0.24 |
chr1_112416405_112416721 | 4.87 |
Gm18406 |
predicted gene, 18406 |
11708 |
0.27 |
chr1_152955157_152955453 | 4.86 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
31 |
0.97 |
chr13_59041258_59041434 | 4.86 |
Gm34245 |
predicted gene, 34245 |
36950 |
0.14 |
chr1_74099202_74099549 | 4.86 |
Tns1 |
tensin 1 |
699 |
0.66 |
chrX_147553490_147553902 | 4.82 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
354 |
0.91 |
chr13_112165997_112166183 | 4.80 |
Gm48802 |
predicted gene, 48802 |
5978 |
0.21 |
chr2_20548366_20548517 | 4.79 |
Etl4 |
enhancer trap locus 4 |
419 |
0.9 |
chr1_167598220_167598410 | 4.76 |
Rxrg |
retinoid X receptor gamma |
69 |
0.98 |
chr13_29349395_29349902 | 4.75 |
Gm11364 |
predicted gene 11364 |
113028 |
0.07 |
chr13_83744885_83745867 | 4.71 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr2_107290011_107290681 | 4.71 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
293 |
0.95 |
chr12_25871193_25871842 | 4.71 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chrX_143543266_143543620 | 4.70 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr2_75989132_75989283 | 4.67 |
Ttc30a1 |
tetratricopeptide repeat domain 30A1 |
7240 |
0.17 |
chr8_71602133_71603459 | 4.66 |
Fam129c |
family with sequence similarity 129, member C |
445 |
0.63 |
chr7_55744599_55744789 | 4.64 |
Siglech |
sialic acid binding Ig-like lectin H |
23484 |
0.17 |
chr9_36933872_36934074 | 4.64 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
53299 |
0.1 |
chr9_33630065_33630387 | 4.58 |
Gm47778 |
predicted gene, 47778 |
32861 |
0.21 |
chr8_26265482_26265685 | 4.58 |
Gm31727 |
predicted gene, 31727 |
1394 |
0.32 |
chrX_53607803_53608436 | 4.57 |
Rtl8c |
retrotransposon Gag like 8C |
87 |
0.92 |
chr19_33391464_33392505 | 4.57 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chrX_102003725_102004324 | 4.57 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr8_105446278_105446429 | 4.53 |
Lrrc36 |
leucine rich repeat containing 36 |
2514 |
0.16 |
chr6_6872048_6872218 | 4.52 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
541 |
0.67 |
chr4_120268142_120268556 | 4.50 |
Foxo6 |
forkhead box O6 |
19000 |
0.2 |
chr7_62415346_62415506 | 4.50 |
Mkrn3 |
makorin, ring finger protein, 3 |
4713 |
0.18 |
chr12_90915906_90916594 | 4.50 |
Gm47688 |
predicted gene, 47688 |
22132 |
0.17 |
chr6_6869992_6870193 | 4.48 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1500 |
0.28 |
chr8_92721661_92721843 | 4.46 |
Gapdh-ps16 |
glyceraldehyde-3-phosphate dehydrogenase, pseudogene 16 |
4777 |
0.22 |
chr1_72739119_72739270 | 4.43 |
Rpl37a |
ribosomal protein L37a |
27413 |
0.14 |
chr12_26635762_26635979 | 4.43 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33561 |
0.18 |
chr16_85171048_85171223 | 4.43 |
Gm27295 |
predicted gene, 27295 |
2286 |
0.26 |
chr9_45626192_45626360 | 4.43 |
Gm22069 |
predicted gene, 22069 |
8536 |
0.21 |
chr5_137553403_137553827 | 4.41 |
Actl6b |
actin-like 6B |
58 |
0.92 |
chr15_26795698_26795849 | 4.41 |
Gm49266 |
predicted gene, 49266 |
49636 |
0.14 |
chr15_52040159_52040613 | 4.38 |
Aard |
alanine and arginine rich domain containing protein |
279 |
0.89 |
chr15_37792138_37792337 | 4.36 |
Ncald |
neurocalcin delta |
2 |
0.98 |
chr5_64490311_64490476 | 4.35 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
13358 |
0.13 |
chr18_42877563_42877943 | 4.34 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
21062 |
0.23 |
chr7_130368893_130369082 | 4.33 |
Gm5903 |
predicted gene 5903 |
14625 |
0.21 |
chr17_48976070_48976428 | 4.33 |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
43870 |
0.18 |
chr10_114801893_114802309 | 4.32 |
Trhde |
TRH-degrading enzyme |
201 |
0.7 |
chr1_5018013_5019021 | 4.31 |
Rgs20 |
regulator of G-protein signaling 20 |
218 |
0.93 |
chr16_63863848_63864067 | 4.29 |
Epha3 |
Eph receptor A3 |
123 |
0.98 |
chrX_70328630_70328781 | 4.28 |
Ids |
iduronate 2-sulfatase |
32386 |
0.12 |
chr2_13793221_13793992 | 4.28 |
St8sia6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
313 |
0.94 |
chr10_39505150_39505369 | 4.27 |
Fyn |
Fyn proto-oncogene |
6480 |
0.22 |
chr8_87747665_87747816 | 4.27 |
Zfp423 |
zinc finger protein 423 |
56083 |
0.15 |
chr9_55026347_55026671 | 4.26 |
Chrna3 |
cholinergic receptor, nicotinic, alpha polypeptide 3 |
21 |
0.96 |
chr15_85613387_85614197 | 4.26 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
31319 |
0.12 |
chr1_84585391_84585851 | 4.24 |
Dner |
delta/notch-like EGF repeat containing |
38220 |
0.17 |
chr4_41665333_41665656 | 4.24 |
Cntfr |
ciliary neurotrophic factor receptor |
1460 |
0.24 |
chr17_93201568_93201863 | 4.24 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
361 |
0.87 |
chr15_57733279_57733651 | 4.23 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
5201 |
0.22 |
chr1_157244183_157244380 | 4.22 |
Rasal2 |
RAS protein activator like 2 |
209 |
0.95 |
chrX_20663071_20663456 | 4.22 |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
365 |
0.81 |
chr10_13967258_13967977 | 4.22 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
593 |
0.75 |
chr2_52946485_52946700 | 4.22 |
Fmnl2 |
formin-like 2 |
88724 |
0.09 |
chr2_158610887_158611072 | 4.22 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
212 |
0.51 |
chr4_118260172_118260464 | 4.21 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
23873 |
0.15 |
chr1_6761310_6761539 | 4.21 |
St18 |
suppression of tumorigenicity 18 |
23849 |
0.23 |
chr12_75179573_75179842 | 4.20 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
2375 |
0.43 |
chr1_9629816_9630624 | 4.20 |
2610203C22Rik |
RIKEN cDNA 2610203C22 gene |
872 |
0.51 |
chr5_30738536_30738777 | 4.19 |
Gm42764 |
predicted gene 42764 |
20376 |
0.12 |
chr10_17178730_17179017 | 4.19 |
Gm25382 |
predicted gene, 25382 |
62069 |
0.13 |
chr5_35129317_35129469 | 4.18 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
23627 |
0.17 |
chr14_21847336_21848481 | 4.18 |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
98 |
0.77 |
chr1_23762182_23762730 | 4.17 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
445 |
0.89 |
chr11_118436435_118436735 | 4.17 |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
2732 |
0.18 |
chr14_14983885_14984321 | 4.17 |
Nek10 |
NIMA (never in mitosis gene a)- related kinase 10 |
53528 |
0.11 |
chr4_109569075_109569277 | 4.15 |
Gm12811 |
predicted gene 12811 |
38 |
0.97 |
chr1_128405021_128405492 | 4.14 |
Dars |
aspartyl-tRNA synthetase |
12103 |
0.18 |
chr17_73713338_73713695 | 4.12 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
3063 |
0.29 |
chr10_105402066_105402230 | 4.11 |
Gm48203 |
predicted gene, 48203 |
7862 |
0.2 |
chr8_72655022_72655548 | 4.08 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
1799 |
0.29 |
chr18_36197046_36197216 | 4.07 |
Nrg2 |
neuregulin 2 |
101 |
0.97 |
chr8_120217063_120217433 | 4.06 |
A330074K22Rik |
RIKEN cDNA A330074K22 gene |
10982 |
0.16 |
chr5_8797889_8798213 | 4.06 |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
96 |
0.86 |
chr10_119086515_119086902 | 4.02 |
Gm18904 |
predicted gene, 18904 |
3634 |
0.18 |
chr9_26519773_26519955 | 4.02 |
Gm30313 |
predicted gene, 30313 |
30089 |
0.22 |
chr2_25319011_25319403 | 4.01 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
20 |
0.93 |
chr18_64017511_64017664 | 4.01 |
Gm6974 |
predicted gene 6974 |
63833 |
0.11 |
chr1_181352530_181353006 | 4.01 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
138 |
0.96 |
chr8_126876416_126877251 | 3.99 |
Gm31718 |
predicted gene, 31718 |
395 |
0.86 |
chr12_53247011_53247372 | 3.99 |
Npas3 |
neuronal PAS domain protein 3 |
966 |
0.69 |
chr18_23862070_23862221 | 3.99 |
Gm23207 |
predicted gene, 23207 |
44774 |
0.11 |
chr6_135376013_135376170 | 3.99 |
Emp1 |
epithelial membrane protein 1 |
8598 |
0.17 |
chr4_154499598_154500103 | 3.98 |
Prdm16 |
PR domain containing 16 |
28915 |
0.17 |
chr13_34089112_34089297 | 3.98 |
Gm47065 |
predicted gene, 47065 |
177 |
0.9 |
chr13_20354575_20355127 | 3.98 |
Elmo1 |
engulfment and cell motility 1 |
71934 |
0.1 |
chr14_59838570_59838988 | 3.96 |
Gm19716 |
predicted gene, 19716 |
196231 |
0.02 |
chr12_105453942_105454636 | 3.96 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
433 |
0.83 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.7 | 8.0 | GO:0021586 | pons maturation(GO:0021586) |
2.1 | 6.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.0 | 5.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.9 | 5.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.9 | 5.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 21.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.7 | 16.6 | GO:0071625 | vocalization behavior(GO:0071625) |
1.6 | 4.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.6 | 6.5 | GO:0060596 | mammary placode formation(GO:0060596) |
1.6 | 4.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.5 | 6.1 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.5 | 4.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.5 | 4.4 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 5.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.4 | 5.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.4 | 4.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 4.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.3 | 5.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.2 | 3.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.2 | 3.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.1 | 6.8 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
1.1 | 5.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 5.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.1 | 3.3 | GO:0033058 | directional locomotion(GO:0033058) |
1.1 | 3.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.1 | 3.2 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.1 | 5.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 3.1 | GO:0061743 | motor learning(GO:0061743) |
1.0 | 12.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.0 | 4.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.9 | 1.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 7.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 3.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.9 | 6.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.9 | 4.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.9 | 3.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 6.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.8 | 2.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 4.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 1.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.8 | 5.6 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.8 | 2.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 3.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.8 | 4.6 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.8 | 3.0 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.7 | 3.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.7 | 2.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 3.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 2.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 3.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.7 | 2.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.7 | 4.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.7 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 2.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 2.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 0.6 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.6 | 1.9 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.6 | 5.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.9 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.6 | 3.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.6 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 1.9 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.6 | 3.7 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.6 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 2.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.6 | 2.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 2.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.6 | 6.6 | GO:0036065 | fucosylation(GO:0036065) |
0.6 | 1.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 2.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 1.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.6 | 1.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 1.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.6 | 8.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.6 | 1.7 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 2.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.5 | 2.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 2.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 2.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 2.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 3.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 2.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.5 | 1.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 0.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.5 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 1.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 2.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.5 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 1.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 1.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 7.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 2.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.5 | 2.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 1.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.4 | 1.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 2.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 2.6 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.4 | 0.9 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 1.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 6.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 1.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 2.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 2.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 2.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 1.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 5.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 1.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 3.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 1.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 2.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 2.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 4.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 4.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.4 | 0.8 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 7.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 1.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.4 | 6.2 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 2.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 0.8 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 1.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 2.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.4 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.5 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 6.8 | GO:0001964 | startle response(GO:0001964) |
0.4 | 19.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.4 | 1.5 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 2.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 1.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 1.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.7 | GO:0086013 | membrane repolarization during action potential(GO:0086011) membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.3 | 1.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 1.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.7 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.3 | 1.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.3 | 1.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 3.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 2.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 2.6 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 1.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 0.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.3 | 2.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.3 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 4.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.5 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.3 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 2.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 1.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.6 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.3 | 2.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.9 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.3 | 0.9 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.3 | 1.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.3 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 0.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 0.8 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 1.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 0.8 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.3 | 2.1 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 2.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 2.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 2.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 1.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 17.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 4.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 3.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 4.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 6.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 2.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 3.1 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 2.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.2 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
0.2 | 0.7 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 1.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 7.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 1.3 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.2 | 1.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.7 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 1.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 8.1 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 3.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.8 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 1.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 1.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.8 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 1.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.2 | 0.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.6 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 2.6 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 1.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 4.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 1.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 15.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.5 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.3 | GO:0043416 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 2.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 1.6 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.2 | 0.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 4.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 4.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 0.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 1.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.3 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.6 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 3.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 1.8 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 1.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 2.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 2.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.7 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.7 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 2.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 1.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.5 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.8 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.4 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.3 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.5 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.1 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.6 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 1.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 2.5 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 2.8 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 1.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.2 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 1.0 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.7 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.7 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.2 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Fc-epsilon receptor signaling pathway(GO:0038095) Kit signaling pathway(GO:0038109) |
0.1 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.9 | GO:0071472 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.2 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.8 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.6 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 1.0 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 1.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.6 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.6 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 1.0 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0008334 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.0 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.0 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.0 | 0.0 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.0 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.2 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) tyrosine metabolic process(GO:0006570) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 1.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.2 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 1.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.0 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.0 | 0.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.2 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.1 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0036257 | multivesicular body organization(GO:0036257) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 11.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.1 | 8.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 6.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.1 | 20.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 5.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.8 | 11.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.5 | 4.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.1 | 2.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.1 | 9.7 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 7.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.0 | 3.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 1.9 | GO:0097433 | dense body(GO:0097433) |
0.8 | 3.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 22.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 5.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 11.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 10.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.6 | 1.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 3.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 2.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 6.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 4.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 4.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 4.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 2.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 29.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 3.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 2.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 3.7 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 5.2 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 4.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 1.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 3.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 14.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 3.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.0 | GO:0044393 | microspike(GO:0044393) |
0.3 | 3.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 0.9 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 7.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 3.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 5.4 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 2.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 3.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 2.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 26.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 2.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 3.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 2.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 13.7 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 2.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.7 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 12.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.7 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 3.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 3.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 2.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 1.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 1.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 2.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 1.7 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 1.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.2 | 6.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.8 | 11.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 4.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.5 | 4.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.3 | 4.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.3 | 3.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 3.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.2 | 3.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.2 | 6.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.2 | 4.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 6.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.2 | 4.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.1 | 3.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.1 | 5.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.1 | 6.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.1 | 3.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.1 | 4.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 12.7 | GO:0016595 | glutamate binding(GO:0016595) |
1.0 | 2.9 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.0 | 6.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 5.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 6.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 22.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 2.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.7 | 2.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.7 | 2.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 3.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.7 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 3.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 12.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 2.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.6 | 2.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 2.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 7.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 5.8 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.5 | 14.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 1.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 4.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 1.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 3.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 10.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 2.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 8.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 4.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 9.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 2.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 3.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 1.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 4.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 2.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.4 | 13.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 2.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 5.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.7 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 2.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 3.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 7.2 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 4.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 1.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 2.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 4.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 5.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 1.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 1.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 2.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 2.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 4.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 4.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 4.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 4.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 2.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 4.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 5.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 3.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 3.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 2.4 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 12.7 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 1.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 3.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 3.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 4.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 5.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 3.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.6 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 3.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.5 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 0.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 4.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 2.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 3.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 5.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 8.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 4.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 1.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.7 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 1.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.4 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 1.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0070191 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.0 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 9.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 6.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 5.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 6.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 6.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 2.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 6.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 4.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 17.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 5.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 11.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.9 | 39.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 9.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 8.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 9.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 7.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 6.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 5.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 5.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 6.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 10.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 3.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 5.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 5.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 4.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 3.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 4.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 7.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 4.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 2.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 4.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 5.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.8 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 5.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 4.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 5.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |